Rhode Island Hospital

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, Rhode Island Hospital sits in the top decile of US sponsors by registered trial count (#210 of 15,742 sponsors by registered trial count).

130 total trials 26 currently recruiting 93 completed early-phase tilt top decile by trial count

Rhode Island Hospital: 130 sponsored US clinical trials, 26 recruiting.

Rhode Island Hospital sponsors 130 registered US clinical trials on ClinicalTrials.gov, 26 of them currently recruiting, and 93 completed. 14 of these trials are in Phase 3-4 (later-stage) and 34 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obsessive - Compulsive Disorder, with 3 trials.

Top-decile sponsor footprint

Rhode Island Hospital ranks in the top decile of sponsors by registered trial count (#210 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

C 70/100

93 of 101 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (92.1%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

130 total, page 3 of 3

COMPLETED Phase 1

Eliciting Affect in Teens in a Virtual World (Project AVATAR)

NCT02338063

COMPLETED NA

ReDIAL: A Telephone Brief Intervention for Injured Emergency Department Patients

NCT01326169

COMPLETED Phase 2

Intervention for Depressed Latina Mothers of Children With Asthma

NCT01326182

COMPLETED Phase 2

Affect Management for Early Adolescents

NCT01197404

COMPLETED NA

Brief Alcohol Intervention to Reduce At-Risk Drinking Among Type 2 Diabetics

NCT00950040

COMPLETED Phase 2

Ultrasound-guided Femoral Nerve Blocks in Elderly Patients With Hip Fractures

NCT01701414

COMPLETED Phase 4

Treatment Trial for Psychogenic Nonepileptic Seizures

NCT00835627

TERMINATED Phase 2

Fetal Tracheal Balloon Study in Diaphragmatic Hernia

NCT00966823

COMPLETED Phase 2

Telephone Support for Dementia Caregivers

NCT00735800

COMPLETED Phase 3

Comparing the Effectiveness of Two Family-based Therapies in Treating Young Children With Obsessive-Compulsive Disorder

NCT00533806

COMPLETED NA

CDC HIV Testing Guidelines: Unresolved Ethical Concerns

NCT00564369

COMPLETED Phase 2

Intranasal Ketamine for Procedural Sedation in Pediatric Laceration Repair

NCT00451724

COMPLETED Phase 1

Family-Based HIV Prevention for Latinos

NCT00582101

COMPLETED Phase 1

Affect Management Intervention for Early Adolescents Wtih Mental Health Problems

NCT00741975

COMPLETED

Evaluating Parenting Styles and Child Temperament Associated With Child Anxiety Disorders

NCT00517244

COMPLETED NA

BC-DAISY: A Breast Cancer Decision Aid System

NCT00347568

COMPLETED Phase 1

Reducing HIV Risk Among Pregnant Women in Drug Treatment

NCT00332813

TERMINATED Phase 4

Hematoma Block as an Adjunct to Procedural Sedation for Forearm Fracture Reduction

NCT00763880

COMPLETED Phase 4

The Effect of a Once Daily Dose of Atomoxetine (ATX) on ADHD-Related Insomnia in Children and Adolescents

NCT00566371

COMPLETED Phase 1

An Affect Management Intervention for Juvenile Offenders

NCT00748800

COMPLETED Early Phase 1

Chlorine Dioxide Versus Saline for Wound Irrigation

NCT01341041

COMPLETED Phase 2

Reducing Alcohol Use in Depressed Patients

NCT00183079

COMPLETED NA

Initial Graft Tension and ACL Surgery

NCT00434837

COMPLETED Phase 4

Treatments for Psychogenic Nonepileptic Seizures (NES)

NCT00159965

COMPLETED Phase 1

Therapeutic Schools: Affect Management and HIV Prevention

NCT00500487

COMPLETED Phase 2

Trazodone for Sleep Disturbance in Early Alcohol Recovery

NCT00027053

COMPLETED Phase 1

HIV Prevention for Youth With Severe Mental Illness

NCT00496691

COMPLETED Phase 3

Family Based Treatment of Early Childhood Obsessive Compulsive Disorder

NCT00055068

COMPLETED Phase 2

Telephone-Based Support for Caregivers of Patients With Dementia

NCT00052104

COMPLETED Phase 1

HIV, Abuse, and Psychiatric Disorders Among Youth

NCT00603369

← Previous Page 3 of 3

Phase Distribution

PhaseTrial count
Phase 1 17
Phase 2 17
Phase 3 3
Phase 4 11

What is open in the Rhode Island Hospital pipeline

26 recruiting of 130 indexed (20% open); 93 completed (72%).

Phase mix: 14 late (III/IV) vs 34 early (I/II) (early-phase heavy).

Top condition: Obsessive - Compulsive Disorder (3 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Rhode Island Hospital: open-pipeline peers nationwide

Peers matched on 130 registered trials and 20% open enrollment, not the therapeutic-area sidebar.

Rhode Island Hospital sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 050100150 5%10%15%20%25% Total trials Recruiting share Rhode Island HospitalNational Institute on Aging (NIA)University of Illinois at Urbana-ChampaignJazz PharmaceuticalsGeorge Washington UniversityAcera SurgicalAlign TechnologyAltruBioAlvernia University
Rhode Island Hospital sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Rhode Island Hospital sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 130 trials (± recruiting share)

Sponsors near 20% open enrollment (± trial volume)

What to do with this Rhode Island Hospital page

130 registered trials is a research-attention snapshot, not an endorsement of Rhode Island Hospital or any single study.

  • 26 of Rhode Island Hospital's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Obsessive - Compulsive Disorder is the condition Rhode Island Hospital studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Obsessive - Compulsive Disorder trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Rhode Island Hospital pipeline card: 130 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.